Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site bruising, Injection site pain
Clinical narrative: The whole area feels warm and is more sore than the other areas; her arm is uncomfortable and a little scary; It was very swollen in the center of her injection site last night; It is sore all the way under her arm and around her shoulder; It is more sore at the sight of the injection though; she had the 3rd dose yesterday; she had the 3rd dose yesterday; it really hurt; wound had a considerable amount of blood; arm developed a bruise the size of a silver dollar; This is a spontaneous report from contactable consumer (patient) via a Pfizer sponsored program. A 68-year-old female patient received third dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: FD8448), via an unspecified route of administration, administered in arm right on 24Aug2021 14:45 (at the age of 68-years-old) as dose 3, single for covid-19 immunisation at pharmacy or drug store. Medical history included mycobacterium avium complex infection and primary immune deficiency disease from 2017 to ongoing. She was immunocompromised and has a primary immune deficiency disease. Also diagnosed with something else that was related to her being immunocompromised. She said that she gets Subcutaneous IG every 2 weeks. The patient mom died of cancer. Investigation Assessment was no. Prior Vaccinations, patient did not receive any other vaccinations within four weeks prior to the first administration date of the suspect vaccine. The patient's concomitant medication included immunoglobulin human normal (CUVITRU) from Jun2017 and subcutaneous IG every 2 weeks. Historical vaccines included Prevnar 13 and Pneumovax vaccine and had no problems with either of them. Additional vaccines administered on same date of the Pfizer suspect was none. The patient previously second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9262), via an unspecified route of administration, administered in arm left on 26Feb2021 as dose 2, single and first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EB5313), via an unspecified route of administration, administered in right arm on 05Feb2021 (at the age of 68-years-old) as dose 1, single for covid-19 immunisation. She did not feel the first injection and the second injection did sting a little. List of any other vaccinations within four weeks prior to the first administration date of the suspect vaccine was none and no prior vaccinations within 4 weeks. Patient reported that on 24Aug2021, she had the 3rd dose and had an unusual reaction. While being vaccinated the dose it really hurt and it was like the vaccine was thick, unlike the previous doses. The wound had a considerable amount of blood. The arm developed a bruise the size of a silver dollar. Caller reported that her arm was uncomfortable and a little scary. It was very swollen in the center of her injection site last night, it had kind of spread out now, it was sore and kind of swollen, but not lumped up then. It was sore all the way under her arm and around her shoulder. It was more sore at the sight of the injection though. The whole area felt warm and was more sore than the other areas. It definitely hurt. She did not feel the lump anymore, it was just a bulging all over then like swelling. She said that there was almost a hard feeling in the centre of its last night. She said that she kept rubbing the front of her chest, was massaging the shoulder and back, and gently rubbing the injection site area. Caller said that she had soreness before with the other 2 vaccines. He did not visit emergency room or physician office. She said that she took some Tylenol and put ice on it for uncomfortable arm. The outcome of events wound had a considerable amount of blood was recovered on 24Aug2021, event arm developed a bruise the size of a silver dollar was recovering, and outcome of other events was unknown, event arm developed a bruise the size of a silver dollar was not resolved.   No follow-up attempts were possible. No further information was expected.